705 related articles for article (PubMed ID: 32317969)
1. Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes.
Lautié E; Russo O; Ducrot P; Boutin JA
Front Pharmacol; 2020; 11():397. PubMed ID: 32317969
[TBL] [Abstract][Full Text] [Related]
2. Natural product source material use in the pharmaceutical industry: the Glaxo experience.
Turner DM
J Ethnopharmacol; 1996 Apr; 51(1-3):39-43; discussion 44. PubMed ID: 9213629
[TBL] [Abstract][Full Text] [Related]
3. Strategies to diversify natural products for drug discovery.
Li G; Lou HX
Med Res Rev; 2018 Jul; 38(4):1255-1294. PubMed ID: 29064108
[TBL] [Abstract][Full Text] [Related]
4. Natural products as a resource for new drugs.
Clark AM
Pharm Res; 1996 Aug; 13(8):1133-44. PubMed ID: 8865302
[TBL] [Abstract][Full Text] [Related]
5. Bioactive Peptide Natural Products as Lead Structures for Medicinal Use.
Dang T; Süssmuth RD
Acc Chem Res; 2017 Jul; 50(7):1566-1576. PubMed ID: 28650175
[TBL] [Abstract][Full Text] [Related]
6. Bioactive agents from natural sources: trends in discovery and application.
Grabley S; Thiericke R
Adv Biochem Eng Biotechnol; 1999; 64():101-54. PubMed ID: 9933977
[TBL] [Abstract][Full Text] [Related]
7. Natural products as a robust source of new drugs and drug leads: past successes and present day issues.
Rishton GM
Am J Cardiol; 2008 May; 101(10A):43D-49D. PubMed ID: 18474274
[TBL] [Abstract][Full Text] [Related]
8. Cheminformatics Explorations of Natural Products.
Prieto-Martínez FD; Norinder U; Medina-Franco JL
Prog Chem Org Nat Prod; 2019; 110():1-35. PubMed ID: 31621009
[TBL] [Abstract][Full Text] [Related]
9. Drugs from the Oceans: Marine Natural Products as Leads for Drug Discovery.
Altmann KH
Chimia (Aarau); 2017 Oct; 71(10):646-652. PubMed ID: 29070409
[TBL] [Abstract][Full Text] [Related]
10. High impact technologies for natural products screening.
Koehn FE
Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
[TBL] [Abstract][Full Text] [Related]
11. Natural product discovery: past, present, and future.
Katz L; Baltz RH
J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
[TBL] [Abstract][Full Text] [Related]
12. The value of nature's natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate.
Ogbourne SM; Parsons PG
Fitoterapia; 2014 Oct; 98():36-44. PubMed ID: 25016953
[TBL] [Abstract][Full Text] [Related]
13. Opportunities for natural products in 21
Wright GD
Nat Prod Rep; 2017 Jul; 34(7):694-701. PubMed ID: 28569300
[TBL] [Abstract][Full Text] [Related]
14. New concepts, experimental approaches, and dereplication strategies for the discovery of novel phytoestrogens from natural sources.
Michel T; Halabalaki M; Skaltsounis AL
Planta Med; 2013 May; 79(7):514-32. PubMed ID: 23479392
[TBL] [Abstract][Full Text] [Related]
15. Biodiversity, chemical diversity and drug discovery.
Singh SB; Pelaez F
Prog Drug Res; 2008; 65():141, 143-74. PubMed ID: 18084915
[TBL] [Abstract][Full Text] [Related]
16. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
17. Biodiversity as a source of anticancer drugs.
Tan G; Gyllenhaal C; Soejarto DD
Curr Drug Targets; 2006 Mar; 7(3):265-77. PubMed ID: 16515527
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Sources for Leads: Natural Products and Libraries.
van Herwerden EF; Süssmuth RD
Handb Exp Pharmacol; 2016; 232():91-123. PubMed ID: 26408018
[TBL] [Abstract][Full Text] [Related]
20. Expanding the chemical diversity through microorganisms co-culture: Current status and outlook.
Arora D; Gupta P; Jaglan S; Roullier C; Grovel O; Bertrand S
Biotechnol Adv; 2020; 40():107521. PubMed ID: 31953204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
